It has been reported that CXCL10 may act in a paracrine fashion affecting the peritumoral CD4+ and CD8+ lymphocytes, and in an autocrine fashion contributing to tumor migration and progression (Mulligan et al., 2013). Here, CD8A is linked to neoplasm.